NCT02237170View on ClinicalTrials.gov

Immune Monitoring on Sipuleucel-T

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Prostate Cancer
Trial Locations (3)

10029

Icahn School of Medicine at Mount Sinai, New York

10065

Weill Cornell Medical College, New York

89169

Comprehensive Cancer Center of Nevada, Las Vegas

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02237170 - Immune Monitoring on Sipuleucel-T | Biotech Hunter | Biotech Hunter